| Labcorp

Warren Rowland

Warren Rowland joined Labcorp Biopharmaceutical CMC Services in 2010. He has more than 20 years of experience in drug development spanning both small and large molecules within research and development/GLP/GMP environments with experience in large pharmaceutical companies and contract research organizations. He holds a BA in chemistry from Monmouth College.

Colin Guy, PhD

Dr. Colin Guy received his PhD (biochemistry) from the University of Nottingham in 2006, and following postdoctoral studies, he joined Labcorp Drug Development in 2010. He has a broad range of experience within the biochemistry field, including in liquid chromatography, capillary and gel electrophoresis and ligand binding assays.

Tobey Gooding

Tobey Gooding began his career more than 20 years ago at Eli Lilly and Company in Indianapolis after graduating with a BA in chemistry and biology from Anderson University. There, as an analytical scientist, he gained experience in both immunochemistry and traditional protein chemistry techniques and supported bulk and parenteral manufacturing, cleaning validation and analytical development.

Henry Fisher, PhD

In his role at Labcorp Drug Development, Dr. Henry Fisher is responsible for working closely with clients to develop LC-MS methods for various modalities for both characterization and GMP validation. His primary expertise is biopharmaceutical characterization by peptide mapping, multi-attribute monitoring and host-cell protein analysis but has experience in a range of LC-MS techniques for characterization of biologics. Much of Henry’s work at Labcorp Biopharmaceutical CMC Services is contributing the innovation efforts to bring new LC-MS capabilities into the business.

Leonard Bell, PhD

Originally a chemistry graduate, Dr. Leonard Bell initially worked in the industry as a peptide chemist. He then returned to university for his MSc (biomolecular technology) and PhD (“Interaction of Metal Ions and the β-Amyloid Peptide”). He subsequently returned to the industry after his postdoctoral work (“Peptides That Protect Cardiomyocytes From Anoxia and Reoxygenation”) and joined Labcorp Drug Development’s Biopharmaceutical CMC Services, specializing in large molecules.

Heather Watson

Heather Watson has 22 years of experience in the pharmaceutical and biotech industry, 14 of those in the CRO environment. Her areas of expertise include method development, validation and sample analysis of PK, PD and ADA (inclusive of NAb) methods, supporting both preclinical and clinical programs. She has experience with a variety of drug molecules including but not limited to ADCs, bi- or tri-specific Abs, biosimilars and gene therapies.

Agnes Zybura, PhD

Dr. Agnes Zybura has extensive knowledge in the fields of molecular neurobiology, pharmacology and biochemistry with expertise in signal transduction pathways, sodium channel biology, electrophysiology, fluorescent imaging techniques, cell culture and PCR-based assays. She serves as a QC scientist within the Molecular Bioanalysis group at Labcorp (Greenfield) where she is responsible for developing and validating qPCR-/dPCR-based assays in support of biodistribution and vector shedding studies in accordance with applicable regulatory guidelines (e.g., GLP, GCP/CLIA).

Guolan Wei

Guolan Wei has more than 20 years of experience in contract research organizations and biotechnology companies. She has expertise in regulated bioanalysis with LC-MS/MS assays and immunoassays (PK, ADA, neutralizing antibodies and biomarkers).

Jill Uhlenkamp, PhD

Dr. Jill Uhlenkamp has nearly 20 years of experience in immunoassay development, with more than a decade of that time spent in regulated bioanalysis for drug development including in both biotech and CRO settings. She has developed or overseen development and validation for a wide range of bioanalytical assays. Her experience includes PK, ADA, NAb, and biomarker assays; preclinical and clinical studies; and small, large and oligonucleotide-based therapeutics in a range of matrices.

James Tunaley, PhD

Dr. James Tunaley has more than a decade of academic research and industrial lab experience in multiple fields, including genomics, genetic engineering, analytical chemistry, molecular biology, cell-based assays and protein expression and purification. He has expertise in supporting clients’ cell and gene therapy molecules through the preclinical and clinical stages of development with projects spanning GLP, GCP and GMP regulations.

Gérer votre santé

Maladies et domaines thérapeutiques

Modalités et méthodes de traitement

Disciplines de laboratoire scientifique

Laboratoires

Secteurs